We are live on !
Find out more
Sheets Smith Wealth Management Portfolio holdings
AUM
$958M
Turnover
10.05%
1-Year Est. Return
21.88%
This Fund
S&P 500
This Quarter Est. Return
+6.41%
1 Year Est. Return
+21.88%
3 Year Est. Return
+83.39%
5 Year Est. Return
+89.43%
10 Year Est. Return
+371.26%
AUM
$424M
AUM Growth
+$27.7M
(+7%)
Cap. Flow
+$7.39M
Cap. Flow % of AUM
Cap. Flow %
1.74%
Top 10 Holdings %
Top 10 Hldgs %
19.84%
Holding
337
New
35
Increased
159
Reduced
70
Closed
17
Avg Time Held
2.2
years
Top 10 Avg Time Held
2.7
years
Top 20 Avg Time Held
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$4.2M |
| 2 |
W.P. Carey
WPC
|
+$4.06M |
| 3 |
LKQ Corp
LKQ
|
+$1.34M |
| 4 |
Labcorp
LH
|
+$1.31M |
| 5 |
Lazard
LAZ
|
+$1.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$2.46M |
| 2 |
Stericycle Inc
SRCL
|
+$2.23M |
| 3 |
Estee Lauder
EL
|
+$1.29M |
| 4 |
Visa
V
|
+$1.21M |
| 5 |
CELG
Celgene Corp
CELG
|
+$1.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 25.72% |
| 2 | Financials | 13.17% |
| 3 | Consumer Discretionary | 12.35% |
| 4 | Healthcare | 11.87% |
| 5 | Technology | 10.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
RTX Corp
RTX
$261B
| $2.15M | 0.51% |
26,746
-1,007
| -4% | -$76.5K |
2013 Q2
18 quarters
|
|
52
FedEx
FDX
$69.5B
| $2.13M | 0.5% |
8,550
+1,735
| +25% | +$397K |
2017 Q3
1 quarter
|
|
53
J.M. Smucker
SJM
$13.6B
| $2.11M | 0.5% |
17,018
+4,500
| +36% | +$500K |
2013 Q2
18 quarters
|
|
54
Gilead Sciences
GILD
$194B
| $2.11M | 0.5% |
29,497
-1,421
| -5% | -$108K |
2013 Q2
18 quarters
|
|
55
Verizon
VZ
$186B
| $2.08M | 0.49% |
39,361
-2,392
| -6% | -$118K |
2013 Q2
18 quarters
|
|
56
Vanguard Morningstar Value ETF
VTV
$191B
| $2.02M | 0.48% |
19,015
+91
| +0.5% | +$9.39K |
2013 Q2
18 quarters
|
|
|
MON
57
DELISTED
Monsanto Co
MON
| $2.02M | 0.48% |
17,300
-500
| -3% | -$59.5K |
2013 Q2
18 quarters
|
|
58
Vanguard Dividend Appreciation ETF
VIG
$113B
| $1.97M | 0.46% |
19,324
+201
| +1% | +$19.8K |
2013 Q2
18 quarters
|
|
59
TJX Companies
TJX
$162B
| $1.97M | 0.46% |
51,444
-2,816
| -5% | -$102K |
2013 Q2
18 quarters
|
|
60
Johnson & Johnson
JNJ
$616B
| $1.95M | 0.46% |
13,933
-319
| -2% | -$44.4K |
2013 Q2
18 quarters
|
|
61
Bank of America
BAC
$358B
| $1.92M | 0.45% |
65,097
+14,225
| +28% | +$392K |
2013 Q2
18 quarters
|
|
62
Invesco S&P 500 Equal Weight ETF
RSP
$97.8B
| $1.91M | 0.45% |
18,899
+588
| +3% | +$57.7K |
2013 Q2
18 quarters
|
|
63
Wells Fargo
WFC
$252B
| $1.9M | 0.45% |
31,308
-729
| -2% | -$41.2K |
2013 Q2
18 quarters
|
|
64
T-Mobile US
TMUS
$171B
| $1.88M | 0.44% |
29,526
-4,090
| -12% | -$250K |
2013 Q2
18 quarters
|
|
65
AT&T
T
$161B
| $1.86M | 0.44% |
63,496
-6,503
| -9% | -$178K |
2013 Q2
18 quarters
|
|
66
Honeywell
HON
$67B
| $1.84M | 0.43% |
13,250
| – | – |
2015 Q1
11 quarters
|
|
67
Skyworks Solutions
SWKS
$18.7B
| $1.82M | 0.43% |
19,175
-3,183
| -14% | -$332K |
2013 Q4
16 quarters
|
|
68
VanEck Intermediate Muni ETF
ITM
$2.14B
| $1.79M | 0.42% |
37,100
-7,500
| -17% | -$361K |
2016 Q2
6 quarters
|
|
69
Pfizer
PFE
$169B
| $1.73M | 0.41% |
50,418
+416
| +0.8% | +$14.2K |
2013 Q2
18 quarters
|
|
70
Stryker
SYK
$113B
| $1.73M | 0.41% |
11,186
+439
| +4% | +$67K |
2013 Q2
18 quarters
|
|
71
Xcel Energy
XEL
$47.7B
| $1.71M | 0.4% |
35,475
-5,900
| -14% | -$293K |
2013 Q2
18 quarters
|
|
72
Enterprise Products Partners
EPD
$79.5B
| $1.68M | 0.4% |
63,569
-128
| -0.2% | -$3.24K |
2013 Q2
18 quarters
|
|
73
iShares Select Dividend ETF
DVY
$23.2B
| $1.68M | 0.4% |
17,038
+360
| +2% | +$34.6K |
2013 Q2
18 quarters
|
|
74
UnitedHealth
UNH
$360B
| $1.62M | 0.38% |
7,354
-649
| -8% | -$138K |
2015 Q1
11 quarters
|
|
75
iShares Core S&P Total US Stock Market ETF
ITOT
$95.9B
| $1.61M | 0.38% |
26,368
+226
| +0.9% | +$13.5K |
2015 Q1
11 quarters
|
|
Similar funds
JWBC
Sheets Smith Wealth Management's Q4 2017 Portfolio in Review
As of Q4 2017, Sheets Smith Wealth Management held 337 positions worth $424M, up 7% from $396M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Sheets Smith Wealth Management's Q4 2017 filing shows 35 new, 159 increased, 70 reduced and 17 closed positions. Its largest new stake was W.P. Carey: 59,339 shares worth $4M. The largest sale was Cardinal Health, an estimated $2.46M.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.
- Sheets Smith Wealth Management's largest Q4 2017 buy was W.P. Carey: 59,339 shares worth $4M.
- Sheets Smith Wealth Management added most to Alibaba in Q4 2017, an estimated $4.2M increase.
- Sheets Smith Wealth Management's biggest Q4 2017 reduction was Stericycle Inc, cutting an estimated $2.23M.
- Sheets Smith Wealth Management fully exited Cardinal Health in Q4 2017, selling an estimated $2.46M.
- Sheets Smith Wealth Management's ten largest holdings make up 20% of its $424M portfolio in Q4 2017.
- Sheets Smith Wealth Management opened 35 new positions and closed 17 in Q4 2017.
- Sheets Smith Wealth Management's portfolio value rose 7% quarter-over-quarter to $424M.
Based on Sheets Smith Wealth Management's 13F filing for Q4 2017, filed 12 Jan 2018.